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Abstract
The Transforming Growth Factor (TGF) b signalling family includes morphogens, such as Nodal and Activin, with important
functions in vertebrate development. The concentration of the morphogen is critical for fate decisions in the responding
cells. Smad2 and Smad3 are effectors of the Nodal/Activin branch of TGFb signalling: they are activated by receptors, enter
the nucleus and directly transcribe target genes. However, there have been no studies correlating levels of Smad2/3
activation with expression patterns of endogenous target genes in a developmental context over time. We used mouse
Embryonic Stem (ES) cells to create a system whereby levels of activated Smad2/3 can be manipulated by an inducible
constitutively active receptor (Alk4*) and an inhibitor (SB-431542) that blocks specifically Smad2/3 activation. The
transcriptional responses were analysed by microarrays at different time points during activation and repression. We
identified several genes that follow faithfully and reproducibly the Smad2/3 activation profile. Twenty-seven of these were
novel and expressed in the early embryo downstream of Smad2/3 signalling. As they responded to Smad2/3 activation in
the absence of protein synthesis, they were considered direct. These immediate responsive genes included negative
intracellular feedback factors, like SnoN and I-Smad7, which inhibit the transcriptional activity of Smad2/3. However, their
activation did not lead to subsequent repression of target genes over time, suggesting that this type of feedback is
inefficient in ES cells or it is counteracted by mechanisms such as ubiquitin-mediated degradation by Arkadia. Here we
present an ES cell system along with a database containing the expression profile of thousands of genes downstream of
Smad2/3 activation patterns, in the presence or absence of protein synthesis. Furthermore, we identify primary target genes
that follow proportionately and with high sensitivity changes in Smad2/3 levels over 15–30 hours. The above system and
resource provide tools to study morphogen function in development.
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Introduction
TGFb signalling controls a diverse set of cellular processes
including cell proliferation, differentiation, apoptosis, and specifi-
cation of developmental fate in vertebrate and invertebrate
species. Disruption of signalling leads to developmental abnor-
malities and disease, including cancer. TGFb comprise a large
family of secreted factors that bind to pairs of membrane receptor
serine/threonine kinases (receptor types I and II), which then
phosphorylate the Smad effectors at their C terminus (P-Smad),
allowing them to complex with the common factor Smad4 leading
to nuclear translocation [1–4]. There are two signalling branches:
One of these includes morphogens like Nodal and Activin, which
activate the Smad2 and Smad3 (Smad2/3) effectors [4]. P-Smads
bind to DNA directly and/or interact with different DNA-binding
partner cofactors such as FoxH1, which bind to specific enhancers
and confer target gene specificity [5]. It is estimated that hundreds
of genes are regulated directly by Smad2/3, most of which are
activated, although some are repressed [5,6]. Several Smad target
genes have been identified during development but only a few
have been shown to be direct [7–9].
The divergent functions of TGFb ligands critically depend on
the concentration to which the responding cell is exposed. Studies
of morphogen gradients have shown that Nodal is a key TGFb
morphogen in vertebrate development responsible for gastrulation,
germ layer formation and patterning, i.e. shaping the embryo by
specifying the axes of the body plan [10]. Therefore, the multiple
functions of Nodal depend on concentration and exposure of cells
to different levels activates specific genes and distinct cell fates
[11,12]. Loss of function mutations in the Nodal gene, including
deletions of regulatory elements that, lead to a reduction of Nodal
levels of expression [13], reveal that the highest level of Nodal
signalling is required during gastrulation for the induction of the
anterior primitive streak, which gives rise to the mammalian
equivalent to Spemann’s organiser. Complementary experiments
in Xenopus embryos, show that increasing amounts of Nodal RNA
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dependent manner, and that the highest level induces Spemann’s
organiser [14]. How signalling levels elicit specific transcriptional
responses within the cell remains elusive. In cell-line transcrip-
tional assays with reporter constructs driven by target gene
promoters, the levels of the activated Smad2/3 (P-Smad2/3)
reflect signalling intensity (ligand activated receptors) and these are
proportionate to the levels of reporter expression. However,
correlation of P-Smad2/3 levels with expression patterns of
endogenous target genes over time during development had not
been examined.
To efficiently manipulate activation of Smad2/3 in a cellular
environment relevant to embryonic development, and where
Nodal/Activin are known to function as morphogens, we used ES
cells. ES cells are pluripotent cells derived from the inner cell mass
of blastocysts. They can self renew in culture indefinitely without
losing their normal karyotype and their ability to differentiate [15].
When they are introduced back to host blastocysts they contribute
to all cells of the embryo including the germ line, indicating their
pluripotent stem cell identity [16,17]. In addition, ES cells can be
manipulated to differentiate in culture and they therefore present
an excellent embryonic system for studying molecular and cellular
aspects of cell fate and differentiation [18]. Mouse ES cells exhibit
high levels of autocrine Smad2/3 signalling and express several
TGFb signalling factors including Nodal [19]. It is difficult to
manipulate signalling as only a weak enhancement of Smad2/3
activation can be achieved by addition of Activin in the medium
[19]. Furthermore, Nodal/Activin treatment of ES cells has
diverse effects: from maintenance of proliferation and pluripotency
of human ES cells [20–22], to their differentiation towards
endoderm [23–26]; a lineage known to depend on robust levels of
Nodal signalling during vertebrate embryogenesis [27]. The
mechanism by which ES cells respond to Nodal/Activin in very
different ways remains unknown. However, levels of Nodal/
Activin seem to be critical for the specific outcome [28].
The intracellular levels of P-Smad2/3 are influenced by the
abundance of receptors, extracellular co-receptors and antagonists,
all of which control the exposure of cells to the ligand. Several of
the genes encoding extracellular and intracellular regulators are
themselves direct downstream targets of Smad2/3 activity
(feedback mechanisms) [6]. In addition, while Activin can bind
and activate the receptors directly, Nodal requires the co-receptor
Cripto [29]. As availability of Cripto determines the activity of
Nodal but not that of Activin, it is impossible to predict the levels
of the activated effectors within the cell, based on levels of
extracellular ligand. Furthermore, the transcriptional activity of P-
Smad2/3 is modulated by intracellular feedback mechanisms
including co-activators and co-repressors [5,30] and therefore, P-
Smad2/3 levels do not always correspond to efficient target gene
expression [19]. It is therefore unknown whether the transcrip-
tional responses downstream of Nodal/Activin follow Smad2/3
activation levels and how the intracellular feedback mechanisms
shape expression patterns over time.
To address how target genes respond to the concentration of P-
Smad2/3, and to bypass the extracellular environment, we placed
the activation of Smad2/3 under an inducible constitutively active
receptor (Alk4*). Thisreceptor is induced by a tetracycline analogue
compound, Doxycycline (Dox), and can phosphorylate Smad2/3 in
the absence of TGFb ligands or other receptors. Furthermore, to
block activation we used the specific inhibitor SB-431542, which
targets the receptors (including the exogenous Alk4*) responsible for
Smad2/3 phosphorylation [31]. We used this system to regulate the
levels of Smad2/3 activation in a time course of induction and
inhibition. We evaluated the activation by western blot and studied
gene expression by microarrays at successive time points. We
screened for genes that followed the Smad2/3 activation patterns.
We then examined their expression during induction over time in
the absence of protein synthesis and found twenty-sevennovel genes
to be upregulated; these genes were therefore considered to be
immediate early primary targets. Semi-quantitative and quantita-
tive PCR confirmed the expression patterns of these genes during
induction/inhibition. Sequence analysis revealed the presence of
conserved FoxH1/Smad2 binding elements [32,33] in several of
these genes supporting that they are direct targets. Furthermore, we
showed that these genes are expressed in early stage mouse embryos
and that their expression depends on Nodal signalling suggesting
that they are relevant to development.
Our findings reveal that Smad2/3 activation levels are converted
proportionately to transcriptional responses in ES cells and
probably in early embryos. In addition to the novel target genes,
regulatory factors (positive and negative) of the TGFb signalling
pathway were among the most readily responsive and direct target
genes (feedback factors). However, the activation of negative
intracellular feedback regulators, which interfere with P-Smad2/3
transcriptional activity, do not appear to have a major effect, as
target gene expression remains sensitive and adjusts quickly to
changes of Smad2/3 activation levels for at least a period of 15–
30 hours. Our ES cell system along with the database containing
the expression profile of thousands of genes in response to changing
Smad2/3 activation over time, provide unique tools for a broad
spectrum of scientists and studies. Understanding how the different
functions of TGFb factors are implemented will provide useful
insights for morphogen function in development, stem cell
maintenance and differentiation, as well as diseases such as cancer.
Results
Efficient manipulation of Smad2/3 activation in TAG1 ES
cells
To address how target genes respond to the concentration of P-
Smad2/3, we bypassed the extracellular environment by placing
Smad2/3 activation under the control of a constitutively active Alk4
receptor (Alk4*), which can phosphorylate Smad2/3 in the absence
of TGFb ligands or other receptors [34]. In addition, we placed the
expression of Alk4* under a tetracycline transactivator responsive
promoter [35]. To turn off Smad2/3 phosphorylation we used the
specific inhibitor SB-431542 (SB) [31], which blocks the TGFb
receptors Alk4/5/7 including the exogenous Alk4*, and is tolerated
well by the ES cells [19]. A green fluorescent protein (GFP) reporter
with an internal ribosomal entry site (IRES) was placed downstream
of the Alk4* open reading frame to allow evaluation of transcription
levels (Figure 1A). The inducible Alk4* construct (pSLTT-AIG) was
stably integrated into the J1 R26/N-NLSrtTA (J1) ES cell line [36].
The J1 cell line contains the tetracycline dependent transactivator
(rtTA) stably integrated via homologous recombination into the
ubiquitously expressed ROSA26 locus. The tetracycline analogue
Dox, was used to activate the rtTA-induced transcription of Alk4*.
An ES cell clone, TAG1, showed high expression of GFP after Dox
treatment (Figure 1B), and therefore, was selected for further
experiments. As Alk4* precedes GFP in the dicistronic construct, it
is expected to be expressed in TAG1 cells.
Alk4* expression and function were tested by analysing the
activation of Smad2 (P-Smad2) after Dox or SB treatment in
western blots. Dox treatment resulted in an upregulation of P-
Smad2 by 2.6-fold after 12 hours, which was maintained up to
24 hours (Figure S1A). No significant changes in total Smad2
levels were observed (Figure S1A). We then followed Smad2
activation (by Dox) and inhibition (by SB) in a time course
Smad2/3 Target Gene Profiling
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present in ES cells, with SB for 6 hours (time point zero; 0) prior to
Dox treatment (Alk4* induction); this pre-treatment was used in all
subsequent time course experiments. During induction of Alk4*
(with Dox), P-Smad2 levels were increased (.5-fold) after 3 hours
compared to time point 0 (T0). As we did not observe any further
increase after 6 or 12 hours, we assumed that activation of
Smad2/3 becomes saturated at this early time point. In the second
phase of the experiment (inhibition), addition of SB inhibitor after
12 hours of induction caused a rapid reduction of P-Smad2 levels
(.5 fold) within the first 3 hours (time point 15). Collectively the
above data show that in TAG1 cells Dox induces functional Alk4*,
Figure 1. A tetracycline/Dox inducible Alk4*-receptor phosphorylates Smad2/3 and activates endogenous and exogenous targets
in ES cells. (A) Schematic representation of the Alk4* inducible expression construct pSLTT-AIG. The tet-on inducible promoter (Ptight) drives the
transcription of a bicistronic message encoding the constitutive active Alk4* receptor (dark grey bar) followed by an internal ribosome entry site
(IRES2, open bar), a GFP reporter (EGFP, black bar) and a polyadenylation signal (pA, light grey bar). The scale bar represents 1kb. (B) Two-colour
FACS analysis of stable TAG1 ES cells cultured in the presence or absence of Dox for 18 hours. The y-axis represents red fluorescence while the x-axis
represents GFP (green) fluorescence, both on a log10 scale. Over 90% (broken line) of the Dox induced (TAG1+Dox) ES cells display specific green
fluorescence compared to the uninduced (TAG1-Dox) cells. (C) Western blot analysis of P-Smad2 levels during Alk4* induction and subsequent SB
inhibition in TAG1 ES cells. Cell extracts of each time point were analysed with P-Smad2, Smad2 and Tubulin (loading control) antibodies. The curve
derives from the densitometry analysis of the P-Smad2 bands on the western blot normalised against the Tubulin bands. All values are expressed
relative to the untreated control (Unt.) represented as 100%. (D) Luciferase assays of the parental J1 cell line (cells that do not contain pSLTT-AIG
construct) and TAG1 ES transfected with the Pitx2 luciferase reporter construct. Bars represent the relative increase of luciferase activity in the induced
cells (blue) compared to uninduced cells (grey), for both J1 and TAG1 ES cells. Error bars represent the standard deviation in biological triplicates
(n=3). (E) Quantitative real-time PCR of Nodal transcript in TAG1 ES cells treated sequentially with Dox inducer and SB inhibitor (at 15 hours in blue
or 12 hours in green). A control set of cells was kept for the duration of the experiment in SB (red line). Relative Nodal transcript abundance is
expressed as the average of 4 PCR reactions (n=4) normalised to the average of the housekeeping control genes Gapdh, Ube, Ywhaz and B2m with
standard error of the mean of PCR reactions. Cells were pre-treated with SB for 6 hours to reduce autocrine-signalling and target gene expression
(time point 0) in (C) and (E).
doi:10.1371/journal.pone.0004268.g001
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system to efficiently manipulate the receptor-dependent phos-
phorylation of Smad2/3 in ES cells.
Exogenous and endogenous target gene expression
follows the Smad2/3 activation profile in ES cells
We examined the transcriptional activity of the Alk4* induced
P-Smad2/3 in the TAG1 system using an exogenous luciferase
reporter 0.9-P1, which is driven by the Smad2 regulated promoter
of Pitx2 gene [19] (Figure 1D) in transient transfection assays. The
reporter activity was increased 2.2-fold in TAG1 ES cells treated
with Dox compared to the untreated control, while no difference
was observed in the parental J1 cells, which contain only the rtTA
and not the inducible Alk4* (Figure 1D).
We also examined the endogenous P-Smad2/3 transcriptional
response downstream of the Dox-induced Alk4* in TAG1 cells by
examining with quantitative reverse transcription PCR (RT-PCR)
the expression profile of the known target gene Nodal over time
(Figure S1B). We found that Nodal expression was upregulated 1.5-
fold within the first 6 hours of activation and 2.5-fold after
12 hours (green trend line in Figure S1B). In untreated cells, Nodal
transcription was increased upon removal of SB after pre-
treatment at time point T0 due to de-repression of the autocrine
signalling (blue trend line in Figure S1B). Nodal expression did not
increase in the cells that SB was maintained throughout the
experiment (red line in Figure S1B). Therefore Nodal, and possibly
other endogenous target genes, respond to the activation of
Smad2/3 downstream Alk4* induction.
The TAG1 cells were then used to perform a two-phase
signalling, Dox/SB, time course experiment. Following 6 hours of
SB pre-treatment, the cells were maintained in Dox for 15 hours
and subsequently treated with SB for 9 hours (Dox/SB15). We
collected mRNA at different time points and analysed Nodal
expression by quantitative RT-PCR (Figure 1E). We repeated the
two-phase experiment to examine the reproducibility of the Nodal
transcriptional responses. In addition, to examine the sensitivity of
the target genes in response to SB treatment, and to see whether
negative feedback mechanisms interfered with their response at
15 hours, in the repeated experiment the inhibitor was added
3 hours earlier (at 12 hours; Dox/SB12). We observed similar
response of Nodal expression in both experiments (Figure 1E; Dox/
SB15 blue and Dox/SB12 green curve). Nodal expression increased
by 1.5-fold in the first 6 hours of induction and peaked at 2.5 fold
after 15 hours, while it was reduced by almost 2-fold in the first
3 hours of inhibition (time point 18) and in 6 hours it returned to
basal levels of expression (time point 21). The fast downregulation
of Nodal upon SB treatment after 12 or 15 hours indicates that
there are no secondary mechanisms activated by Smad2/3 over
time and that the Nodal promoter remains sensitive to changes of
Smad2/3 activation in ES cells. In TAG1 cells cultured
continuously (30 hours) with SB inhibitor (red trend line in
Figure 1E), Nodal levels were maintained at basal levels indicating
that Smad2/3 activation is responsible for the upregulation of
Nodal under Dox/Alk4* induction. Collectively the above data
show that the manipulation of Alk4*-Smad2/3 activation in
TAG1 ES cells elicit downstream transcriptional responses on
both exogenous and endogenous promoters.
Sixty genes followed directly the pattern of Smad2/3
activation in TAG1 ES cells
We screened for additional P-Smad2/3 target genes that follow
the expression profile of Nodal using microarrays (Affymetrix) on
the mRNA samples collected from the various time points in two
experiments described above, Dox/SB15 and Dox/SB12
(Figure 1E). We considered as target genes those that meet the
following criteria: upregulation by $1.2 fold in the second or third
time point during induction; downregulation by $1.2 fold at least
in one of the time points during inhibition; genes were not
included if one of the set probes did not behave similarly in both
experiments; or the ‘‘p’’ values were not statistical significant
(p.0.01) at any of the time points.
In total, 64 genes satisfied the criteria in both experiments
(Table 1, Table S1 and Table S2). This list of genes included
known Smad2/3 target genes such as Nodal, Pitx2, Lefty1 and Lefty2
[33,37], which indicate that our criteria were appropriate for the
identification of targets. The Alk4 receptor (Acvr1) was also found
in the list; however, it cannot be distinguished from the exogenous
Alk4*, which is upregulated by Dox/rtTA, and therefore, cannot
be included in our list of Smad2/3 targets.
To exclude the possibility that any of the 64 target genes
responds to Dox/rtTA and not to P-Smad, we performed
microarray analysis on the parental J1 cells (containing rtTA,
but not Alk4*) after 6 and 12 hours of induction with Dox (Table 1
and Table S1). Several genes were upregulated by the rtTA
(ArrayExpress database); however, from the list of 64 genes only
four showed a significant increase in J1 cells as high as in the
TAG1 cells, suggesting that these four genes respond to rtTA
rather than to Alk4*-Smad2/3 activation and were removed from
the list of Smad2/3 targets. Two genes GalNAcS-6ST and Fgf15
respond to rtTA (Table 1: up to 7.34- and 3.16-fold respectively),
but they were upregulated to a greater level in the Dox treated
TAG1 cells (Table 1: up to 36.32- and 15.146-fold respectively)
and therefore, were considered as Smad2/3 targets.
Among the remaining 60 genes, four (Pitx2, Nodal, Lefty1 and
Lefty2) are known direct targets of Nodal during early embryo-
genesis. Smad7 and SnoN have not been shown to be downstream
P-Smad2/3 during early development; however, tissue culture
assays indicated that they are direct targets [38,39]. We therefore
identified 54 new P-Smad2/3 candidate direct target genes in ES
cells. Several other known Smad2/3 target genes were not found
in our screen, because they are either repressed in ES cells or they
require additional partner factors, which are not present in ES
cells. Alternatively, they do not meet our stringent criteria. As Alk4
and Alk4* may also activate other pathways [40], we cannot
exclude the possibility that some of the transcriptional responses
may be due to activation of Smad independent signalling.
However, as in this study we correlate the level of target gene
expression with that of P-Smad2/3 and not Alk4*, we refer to
these genes as Smad2/3 targets rather than Alk4* and Smad2/3.
We analysed the expression profile for the 60-upregulated target
genes throughout the course of the activation and inhibition of
Alk4*-Smad2/3. The microarray data for each gene was plotted as
trend-lines showing the fold-change in log scale compared to the
time point 0 (SB pre-treated cells), when there is no detectable P-
Smad2/3 (Figure 2). We classified the upregulated genes in three
main groups based on their fold-change at time point 15 (highest
value): ‘‘high response’’, ‘‘medium response’’ and ‘‘low response’’
(Table 1 and Figure 2). Notably, this classification inversely reflects
the basal level of expression of the target genes at time point 0,
when Smad2/3 activation has been inhibited with SB for 6 hours.
Therefore, genes with very low basal levels of expression (Table 2)
show the highest fold change in response to Alk4*-Smad2/3
activation, suggesting that in ES cells the expression of these genes
depends solely on P-Smad2/3. In this group we found 5 genes (6
probes) that show an upregulation higher than 10-fold (Figure 2A).
For example Pitx2 is upregulated as much as 100-fold and Lefty1 by
52-fold. In this group we also found GalNAcS-6ST
Smad2/3 Target Gene Profiling
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High Response Targets (10- to 100-fold)
Tag1 Cells J1 cells
Gene Probe Sets ID Accession 0h–15h (Dox) 0h–21h (Dox/SB) 0h–12h (Dox)
Pitx2 1424797_a_at U80011 100 29.398 1.572
Lefty1 1417638_at NM_010094 51.985 6.470 2.215
GalNAcS-6ST 1452092_at AK019474 36.318 5.456 7.34
Lefty2 1436227_at AV214969 22.692 5.450 21.008
Pitx2 1450482_a_at AB006320 20.173 4.568 1.519
Fgf15 1418376_at NM_008003 15.146 7.666 3.16
Medium Response Targets (2.5- to 10-fold)
Tag1 Cells J1 cells
Gene Probe Sets ID Accession 0h–15h (Dox) 0h–21h (Dox/SB) 0h–12h (Dox)
1443256_at 1443256_at BB548833 8.196 5.175 2.237
Pcdh8 1447825_x_at BB076893 7.615 4.729 1.762
AW548124 1454838_s_at BB323985 7.440 2.136 21.139
Duxbl 1445710_x_at AV321065 5.521 4.768 3.497
Smad7 1423389_at BF226166 4.977 1.848 21.277
Tmem63a 1423871_at BC019442 4.956 1.866 1.112
Smad7 1443771_x_at BB241324 4.792 1.771 21.133
AW548124 1460411_s_at BC022157 4.593 1.696 21.078
Tmepai 1422706_at AV370981 4.066 21.040 21.058
Cnpy1 1437996_s_at BB131676 3.944 2.118 1.74
Nxn 1422465_a_at BB366804 3.674 3.094 1.689
Bcar3 1415936_at NM_013867 3.315 2.352 1.454
Pycr2 1448315_a_at NM_133705 3.314 1.782 21.034
Cd97 1418394_a_at NM_011925 3.044 1.714 1.48
Plekha2 1417288_at NM_031257 2.883 1.695 1.035
Slc7a7 1447181_s_at AI790233 2.727 2.362 1.552
Lgr4 1433891_at BI107632 2.625 1.637 1.171
Camk2n1 1456609_at BE994488 2.583 1.601 1.356
Slc7a7 1417392_a_at NM_011405 2.578 2.243 1.565
Low Response Targets (1.2- to 2.5-fold)
Tag1 Cells J1 cells
Gene Probe Sets ID Accession 0h–15h (Dox) 0h–21h (Dox/SB) 0h–12h (Dox)
Abcg2 1422906_at NM_011920 2.386 1.597 1.223
SnoN 1422054_a_at U36203 2.355 2.227 1.855
Rasd2 1427344_s_at BC026377 2.331 1.152 21.091
Dusp9 1433845_x_at AV295798 2.316 2.058 1.306
Bhlhb8 1449233_at BC011486 2.292 1.897 1.966
Sntb2 1449840_at BI646094 2.260 1.285 21.063
Dusp9 1454737_at AV295798 2.236 1.770 1.054
Nphs1 1422142_at AF172256 2.225 1.744 1.634
Nodal 1422057_at X70514 2.138 21.243 1.088
SnoN 1452214_at AK018608 2.041 1.927 1.532
Notch3 1421965_s_at NM_008716 2.027 1.675 21.043
Tmepai 1422705_at AV370981 1.995 21.150 1.235
D6Wsu176e 1417953_at AK016470 1.994 1.551 1.28
Ubr7 1433479_at AV030071 1.923 1.472 1.188
Pea15 1416407_at AI323543 1.908 1.449 1.227
Ubr7 1454616_at AV030071 1.863 1.375 1.436
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be a P-Smad2/3 target. However, its pattern of expression during
early development (gastrulation) is consistent with being a Nodal
regulated gene [41].
The medium response group consists of 16 genes (19 probes)
that show a moderate upregulation ($2.5- and ,10-fold;
Figure 2B). The 39 remaining genes (45 probes) are weakly
upregulated ($1.2- to ,2.5-fold) and form part of the low
response group (Figure 2C). Notably, this last group includes the
known direct target Nodal (fold-change 2.1) and SnoN (fold change
2.3) indicating that the rest of the genes of this group have good
probability to be direct targets. The low fold-change implies that
they have high basal levels of expression at time point 0 and
therefore, are also regulated independently of Alk4*-Smad2/3.
Different probe-sets coding for the same gene were consistently
found within the same group, except for the gene Tmepai, which
has 3 probe in two different groups and belongs to both categories.
In addition, the majority of the 60 genes are reproducibly grouped
into the same category in the two different Dox/SB experiments
(Table S1 and S2). Only 9 genes switched category between
experiments (highlighted genes in Table S2).
Using different methods such as semi-quantitative and quanti-
tative-PCR we confirmed the expression pattern of a subset of
genes included in our list (Figure S2). We concluded that the
identified 54 novel genes are candidates for being direct, as they
reproducibly and readily follow the activation patterns of Smad2/
3 over time.
Direct P-Smad2/3 transcriptional responses occur by de-
repression of Alk4* in the absence of protein synthesis
To examine how direct the response of the identified genes is,
and to ensure that they are immediate targets of Alk4*-Smad2/3
Low Response Targets (1.2- to 2.5-fold)
Tag1 Cells J1 cells
Gene Probe Sets ID Accession 0h–15h (Dox) 0h–21h (Dox/SB) 0h–12h (Dox)
Cripto 1450989_at AV294613 1.841 1.706 21.372
Bbc3 1423315_at AW489168 1.826 1.073 21.043
Gpr107 1459788_at BB115649 1.761 21.010 21.874
Schip1 1423025_a_at NM_013928 1.761 1.349 21.011
Epha2 1421151_a_at NM_010139 1.725 1.405 21.405
Ppp1r2 1417341_a_at NM_025800 1.651 1.382 1.185
Rhob 1449110_at BC018275 1.636 1.224 21.295
Ski 1429192_at AV381512 1.625 1.214 21.047
Zcchc11 1437395_at BE370775 1.596 1.355 1.137
Atrx 1420948_s_at BB825830 1.562 1.206 1.087
Mcl1 1416881_at BC003839 1.549 1.308 1.046
Zfp423 1419380_at NM_033327 1.535 1.032 1.135
Ccnd2 1416122_at NM_009829 1.501 21.582 1.064
Eif3s6ip 1437948_x_at BB443362 1.499 21.067 21.386
Ccnd2 1434745_at BQ175880 1.438 21.524 1.141
5730419I09Rik 1437003_at BB323930 1.424 21.018 1.08
Aasdhppt 1428757_at AK013111 1.416 1.127 21.043
Dppa2 1453223_s_at AK010743 1.415 1.327 1.112
Fbxl20 1456378_s_at AV120094 1.356 1.110 21.102
Moap1 1448787_at BC014715 1.346 1.132 1.076
B3galt3 1418736_at BC003835 1.343 21.839 21.844
Khsrp 1436813_x_at BB332580 1.336 21.043 21.26
BC037674 1434835_at BM230523 1.309 1.007 1.134
Mrpl15 1430798_x_at AV306676 1.307 21.338 21.473
D030056L22Rik 1423879_at BC020125 1.304 1.040 21.018
Ttc13 1437709_x_at BB492914 1.270 1.017 1.106
Nfkbia 1420088_at AI462015 1.225 21.081 21.229
Hrb 1426923_at BB130716 1.215 21.020 1.034
Numbers correspond to fold change values for identified target genes at selected time points (0–15 and 0–21 hours) in TAG1 and J1 cells (0–12h). At time point 0 TAG1
and J1 cells have been pre-treated with SB for 6 hours to turn-off all Smad2/3 signalling. At 15 hour TAG1 cells have been treated only with Dox and at 21 hours cells
have been treated sequentially with Dox for 15 hours followed by SB for another 6 hours. J1 parental cells have been treated for 12 hours only with Dox. Sixty-nine
probe-sets coding for 60 target genes are ranked based on the fold change of gene expression at 15 hours (h) under Dox induction.
doi:10.1371/journal.pone.0004268.t001
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PLoS ONE | www.plosone.org 6 January 2009 | Volume 4 | Issue 1 | e4268activation we performed the activation of Smad2/3 in the absence
of protein synthesis. This was achieved using cycloheximide
(CHX) a protein translation-elongation inhibitor. We pre-treated
the TAG1 cells with SB inhibitor for 6 hours (time point 26) and
subsequently for another 6 hours (time point 0) with Dox in the
presence of SB. During this treatment signalling was inhibited for
12 hours while Alk4* protein was produced in the last 6 hours of
this period in TAG1 cells with minimal activation of Smad2/3.
Subsequently, we removed the SB inhibitor and added CHX to
allow phosphorylation of Smad2/3 by the accumulated Alk4*
preventing any novel translation from the activated downstream
Smad2/3 target genes. Under these conditions we were able to
follow over a period of 12 hours the resulting primary transcrip-
tional responses downstream Smad2/3 activation (Figure 3).
Western blot analysis of P-Smad2 levels at different time points
during this experiment, showed minimal activation of Smad2 by
Dox treatment in the presence of SB inhibitor (Figure 3A, 26t o
0 hours), whereas P-Smad2 reached maximum levels only 2 hours
after removal of SB in the presence of CHX (Figure 3A). P-Smad2
levels stayed at maximum for 4 hours and were gradually depleted
(Figure 3A) most likely due to decay of the ALK4*. protein pool.
Phosphorylation of Smad2 was not observed in a control
experiment where SB inhibitor was maintained throughout the
experiment in the presence of CHX (data not shown). These
Figure 2. Expression profile of genes responding to the manipulation of Alk4*-Smad2/3 activation in ES cells. Microarray expression
analysis of TAG1 ES cells treated sequentially with Dox (activation; 6–15 hours) and SB (inhibition; 18–21 hours). The behaviour of 33 Smad2/3
upregulated genes at different time points (x-axis) during the treatment is represented with trend lines. All samples were normalised to control time
points (0) and the relative level of gene expression is presented as the log values of fold change (the y-axis). For all values see Table S1. (A) Trend lines
showing the expression profile for genes classified as high response targets ($10-fold upregulation in gene expression at time point 15 hours). (B)
Trend lines showing the expression profile of a sub-set of medium response genes, which increases by $2.5- to ,10-fold. (C) Trend lines for a subset
of low sensitivity response genes, which are upregulated by $1.2- to ,2.5-fold.
doi:10.1371/journal.pone.0004268.g002
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in the absence of protein synthesis.
We followed the transcriptional responses downstream Smad2/
3 activation in the absence of protein synthesis by analysing the
expression of the direct target gene Pitx2, by quantitative PCR
(Figure 3B). We found that in two different biological replicate
experiments Pitx2 was activated as early as 2 hours after Alk4* de-
repression (removal of SB). Its expression continued to increase at
4 hours (Figure 3B, lines 1A and 2A) and gradually declined after
that following the decrease in P-Smad2 levels. Pitx2 was not
activated in the cells where SB inhibitor was maintained
throughout the experiment in the presence of CHX, indicating
that it responded to Smad2/3 activation and not to CHX
(Figure 3B, line 1B). Therefore, this system can be used to identify
the primary and immediate early transcriptional responses
downstream Smad2/3 activation in ES cells and to assess the
sensitivity of their response.
Thirty-three out of the sixty target genes responded to
Smad2/3 activation in the absence of protein synthesis
To identify which of the 60 target genes were activated by
Smad2/3 without the requirement of intermediate proteins and in
the absence of feedback factors, we performed microarray analysis
of mRNA at different time points under the conditions described
above (Alk4* de-repression upon removal of SB in the presence of
CHX). We found that 33 out of 60 genes were upregulated by at
least 1.2-fold (P.0.01) at 2 or 4 hours after Alk4* de-repression
(Table 3), when P-Smad2 levels were highest and saturated
Table 2. Basal levels of expression of Smad2/3 target genes
in ES cells
Gene CHX Dox/SB15 Dox/SB12
Duxbl 0.165 0.116 0.073
1443256_at 0.397 0.172 0.260
Cnpy1 0.206 0.108 0.135
Camk2n1 0.383 0.239 0.170
GalNAcS-6ST 0.024 0.026 0.058
Ubr7 3.045 3.846 3.620
Ubr7 1.750 2.306 2.020
5730419I09Rik 1.045 0.712 0.609
Aasdhppt 2.216 2.144 1.662
Abcg2 1.924 1.677 1.008
Gpr107 1.820 0.787 0.093
Atrx 0.964 0.693 0.335
AW548124 0.468 0.229 0.147
AW548124 0.089 0.078 0.057
B3galnt1 0.421 0.411 0.220
Bbc3 1.316 0.857 0.273
BC037674 5.230 4.315 2.803
Bcar3 1.028 0.597 0.432
Bhlhb8 0.367 0.250 0.059
Ccnd2 1.599 0.699 0.551
Ccnd2 1.025 0.471 0.208
Cd97 1.019 0.426 0.656
Cripto 3.506 4.914 3.064
D030056L22Rik 2.981 2.192 1.021
D6Wsu176e 2.482 3.764 3.057
Dppa2 6.387 6.426 4.827
Dusp9 1.995 0.914 0.893
Dusp9 1.978 0.887 0.846
Eif3s6ip 1.172 0.854 0.523
Epha2 2.271 2.591 1.436
Fbxl20 3.094 1.753 0.400
Fgf15 0.596 0.117 0.055
Hrb 2.794 2.951 1.841
Khsrp 1.972 1.233 1.097
Lefty1 0.366 0.531 0.054
Lefty2 0.073 0.160 0.057
Lgr4 2.608 1.822 1.890
Mcl1 5.911 8.708 6.379
Moap1 2.283 3.018 2.214
Mrpl15 1.469 1.519 0.691
Nfkbia 5.817 4.291 2.193
Nodal 1.448 1.196 1.502
Notch3 1.581 0.990 0.297
Nphs1 1.046 1.521 1.363
Nxn 1.788 0.559 0.675
Pcdh8 0.247 0.090 0.056
Pea15 2.070 0.957 0.666
Pitx2 0.031 0.025 0.061
Pitx2 0.277 0.083 0.096
Gene CHX Dox/SB15 Dox/SB12
Plekha2 0.503 0.447 0.272
Ppp1r2 2.998 2.632 2.404
Pycr2 1.927 2.978 2.758
Rasd2 0.418 0.376 0.125
Rhob 1.645 1.230 0.634
Schip1 2.863 3.048 2.337
Ski 1.772 1.506 0.928
Slc7a7 2.619 1.881 1.236
Slc7a7 4.194 3.241 2.620
Smad7 0.904 0.523 0.359
Smad7 0.330 0.191 0.147
SnoN 4.403 3.634 3.292
SnoN 0.505 0.403 0.176
Sntb2 1.049 0.668 0.396
Tmem63a 0.187 0.195 0.134
Tmepai 0.406 0.211 0.191
Tmepai 0.690 0.242 0.189
Ttc13 2.465 1.757 1.376
Zcchc11 3.293 1.876 1.015
Zfp423 1.953 1.948 1.383
Sixty-nine probe sets coding for 60 target genes are listed in alphabetical order.
Numbers correspond to intensity values at time point 0 of each experiment
Dox/SB15 (Table 1 and Table S2), Dox/SB15 (Table S2) and CHX (Table 3). At
time point 0 TAG1 cells have been pre-treated with SB for 6 hours to turn-off all
Smad2/3 signalling.
doi:10.1371/journal.pone.0004268.t002
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directly downstream P-Smad2/3.
This new list of genes includes all the known Nodal/Smad2/3
direct targets present in the list of 60 genes (i.e. Pitx2, Lefty1, Lefty2,
Smad7, SnoN and Nodal), confirming that the conditions and criteria
of the experiment are appropriate for the identification of direct
target genes. We classified these 33 target genes into the same 3
categories of responses (high, Figure 4A; medium, Figure 4B; and
low, Figure 4C), as in the previous Dox/SB experiments, based on
the fold of induction at 4 hours (Table 3). In the absence of protein
synthesis Pitx2 (57-fold), GalNAcS-6ST (47-fold) and Lefty1 (36-fold)
also reached high levels of expression and were classified, as
before, in the high response group (Figure 4A). In general, the fold
of induction was weaker in the presence of CHX, compared to the
induction in the presence of Dox and protein synthesis, suggesting
that peak levels were not achieved. This could be because co-
factors downstream Smad2/3 are required for their activation or
for mRNA stability. However, two genes, Rhob and Camk2n1 had a
higher fold of induction in the absence of protein synthesis
(compare Table 1 and Table 2). This could be because in the
presence of protein synthesis these genes are under a moderate
repression or because their RNA is unstable by a gene specific
negative feedback. As SB pre-treatment of TAG1 cells for
12 hours may not have eliminated completely Smad2/3 phos-
phorylation, some residual feedback factor may have been
produced and remained stable during the CHX treatment.
However, such leaky expression of secondary factors is expected
to be low and die off quickly in the absence of protein synthesis.
Such factor could produce mostly weak expression of secondary
target genes at levels, which are below the cut-off point (,1.2 fold)
after 4 hours of de-repression (P-Smad2/3 activation). In conclu-
sion, our study revealed that among the 60 identified Smad2/3
target genes, 33 (27 novel) are most likely activated directly,
whereas the rest (Table S3) do not show significant upregulation
suggesting that they require intermediate proteins and/or partners
factors for their activation.
FoxH1/Smad2 elements and Smad binding sites are
present in the identified target genes
The Smad2/FoxH1 signalling pathway acts through FoxH1
binding at defined elements [32,33]. The known Smad2/3 target
genes Nodal, Lefty2 and Pitx2 contain pairs of FoxH1 binding sites
separated by 30–200 bps [33,42,13,43] these were termed
asymmetric elements (ASEs) as they drive Nodal-dependent
asymmetric gene expression. To investigate whether our
Smad2/FoxH1 candidate direct target genes contained ASE-like
sequences, we undertook a bioinformatics analysis. Mouse
genomic sequence, encompassing loci plus 10kb each of upstream
and downstream sequence, was screened for pairs of FoxH1
binding sites within 30–200 bps of each other; all possible
sequence orientations were tested (as described in the Materials
and Methods). According to this definition, 19 of 39 loci examined
contained an ASE (Table S4), suggesting that these genes respond
to Smad2/FoxH1 through an ASE and they are direct targets of
Nodal signalling. There was, however, no correlation between the
number of putative ASEs and the levels of expression.
Multispecies sequence comparison has previously demonstrated
conservation of functionally important transcription factor binding
sites [44,45]. If the putative ASEs that we have identified are
significant in vivo, similar sequence conservation would be
expected. Therefore, MultiPipmaker analysis was used to compare
the putative mouse ASE sequences with the corresponding
sequences from human, chimp, dog and rat. Pairwise alignments
of sequence from these species with the mouse sequence were
computed and the resulting alignments were summarised as
‘‘percent identity plot’’ or ‘‘Pipplot’’ (Figure S3). Three different
levels of putative ASE conservation were observed: high cross
species conservation was seen for the known Smad2/FoxH1
Figure 3. Expression profile of Pitx2 downstream a Smad2/3
activation time-course in the absence of protein synthesis. (A)
Western blots of extracts derived from TAG1 ES cells untreated (unt);
pre-treated with SB inhibitor for 6 hours (26); and under SB for
12 hours but given Dox for the last 6 hours to also induced (Dox) and
synthesised Alk4* receptor protein (0). The rest of the samples are
extracts from cell treated as at time ‘‘0’’ but subsequently de-repressed
for different time periods (2), (4), (6), (8) and (12) hours by removal of SB
in the presence of CHX protein synthesis inhibitor. Protein levels were
analysed with antibodies against P-Smad2, Smad2 and Tubulin, PCNA
controls. The curve chart shows densitometry measurements of the P-
Smad2 bands normalised against Tubulin (control). All values are
expressed relative to the untreated control (Unt.) represented as 1.0 (B)
Real-time PCR data showing changes in the expression levels of
endogenous Pitx2 during the manipulation of Smad2/3 phosphoryla-
tion in the absence of protein synthesis (curve 1A and 2A derives from
biological replicate experiments under CHX with Smad2/3 activatio,
while 1B derives from cells under CHX and SB inhibited in all time
points). Relative Pitx2 transcript abundance is expressed as the average
of 4 PCR reactions (n=4) normalised to the average expression of
housekeeping controls Gapdh, Ube, Ywhaz and B2m with standard error
of the mean of PCR reactions.
doi:10.1371/journal.pone.0004268.g003
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Direct Targets with $10.0-Fold Increase in absence of protein synthesis at 0h–4h
Gene 0h–2h 0h–4h 0h–6h 0h–8h 0h–12h
Pitx2 24.973 57.631 36.798 37.593 12.979
GalNAcS-6ST 9.328 47.469 9.708 7.867 2.411
Lefty1 22.993 36.326 28.388 17.475 3.883
Direct Targets with 2.5 to 10.0-Fold Increase in absence of protein synthesis at 0h v 4h
Gene 0h–2h 0h–4h 0h–6h 0h–8h 0h–12h
Lefty2 1.943 5.779 4.207 4.013 2.021
Smad7 3.697 5.668 3.782 2.698 1.928
Camk2n1 3.843 4.813 2.546 1.961 1.164
Duxbl 2.32 4.743 5.974 8.471 7.473
Tmepai 2.209 3.926 2.44 1.826 21.244
Tmepai 2.193 3.735 2.665 2.35 1.184
Smad7 3.095 3.436 2.31 1.887 1.606
Rhob 2.517 3.375 3.537 3.155 2.3
Tmem63a 1.256 3.371 3.957 5.154 4.546
Pitx2 1.68 3.079 2.349 1.989 1.401
AW548124 1.091 2.735 1.33 1.216 1.856
Direct Targets with 1.2 to 2.5-Fold Increase in absence of protein synthesis at 0h v 4h
Gene 0h–2h 0h–4h 0h–6h 0h–8h 0h–12h
SnoN 1.527 2.435 1.499 1.364 1.063
Nodal 2.187 2.358 2.076 1.493 21.768
1443256_at 1.851 2.337 2.073 1.583 1.267
Rasd2 1.137 2.144 2.523 2.527 2.172
SnoN 1.406 2.063 2.108 1.947 1.376
Cd97 1.391 2.036 2.587 2.696 2.811
Epha2 2.161 1.981 1.099 21.454 22.433
Mcl1 1.564 1.966 1.943 1.768 1.631
Pycr2 1.391 1.853 1.963 2.44 2.293
Nfkbia 1.565 1.654 2.14 1.842 1.904
Moap1 1.482 1.634 1.667 1.199 1.364
Bcar3 1.358 1.609 1.858 1.671 1.262
Pcdh8 1.256 1.491 1.371 1.317 1.399
Ubr7 1.224 1.485 1.714 1.744 1.496
D030056L22Rik 1.25 1.414 1.115 21.158 21.198
Cnpy1 1.175 1.405 22.408 22.164 22.409
Plekha2 1.08 1.346 1.591 1.803 1.846
Zcchc11 1.089 1.287 1.088 21.071 1.019
Schip1 1.138 1.286 1.306 1.048 21.055
Slc7a7 1.161 1.265 1.267 1.034 1.063
Zfp423 1.033 1.254 1.366 1.221 1.007
Ubr7 1.165 1.236 1.417 1.464 1.453
AW548124 1.04 1.232 1.05 1.149 1.416
Fbxl20 1.023 1.23 1.439 1.464 2.185
Nxn 1.044 1.203 1.405 1.558 1.136
Fold-change of expression for 38 probe sets coding for 33 target genes at indicated time points after removal of SB and Smad2/3 activation in the absence of protein
synthesis compared to the time point 0 hours. At time point 0 the TAG1 cells have been pre-treated with SB for 6 hours and with SB + Dox for an additional 6 hours.
Genes are classified in descending order with the genes showing the strongest upregulation 4 hours after activation of Smad2/3.
doi:10.1371/journal.pone.0004268.t003
Smad2/3 Target Gene Profiling
PLoS ONE | www.plosone.org 10 January 2009 | Volume 4 | Issue 1 | e4268targets (Nodal, Pitx2, Lefty1 and Lefty2) as well for one putative ASE
in Zfp423 (Figure S4). Interestingly, the predicted ASEs of the
majority of potential novel Smad2/FoxH1 targets were conserved
specifically in rodents suggesting that in other species these sites
have changed position or got lost. A small number of putative
ASEs showed no cross species conservation at all (Figure S4).
Identified as components of the TGFb inducible elements in the
PAI-1 locus, CAGA boxes can bind both Smad3 and 4 [46]. The
presence of CAGA boxes was screened for in 33 loci that were
directly regulated by Smad2/3 in the absence of protein synthesis,
and an additional 6 loci that were only upregulated in the
presences of protein synthesis (Table S4). As expected for a short
single sequence, many CAGA boxes were predicted in most of the
39 genes, irrespective of the presence of ASEs. Notably, no CAGA
boxes were predicted at Pitx2, a locus with previously characterised
ASE elements. Similarly, no close physical proximity was detected
between ASE elements and CAGA boxes in those genes where
putative ASE elements were predicted. The above data support
the hypothesis that most of the identified target genes are regulated
directly by Smad2/3FoxH1 and therefore are direct Nodal targets.
The expression of direct target genes depends on Nodal
signalling in the early embryo
The majority of the novel target genes identified in our system,
have not been studied at early developmental stages. Nodal/
Smad2/3 signalling is essential for gastrulation and patterning of
the anterior posterior axis of the vertebrate embryo. To investigate
the extent to which the identified target genes are relevant to
Nodal signalling in the embryo, we examined their expression in
early mouse embryos (embryonic day 5, E5, and 6, E6) when
Nodal signalling is active. The expression of the target genes was
examined using RT-PCR. In addition, we tested whether the
expression of these genes is dependent on Nodal signalling, by
culturing E5 embryos in defined medium with or without SB
inhibitor for 18 hours prior to RT-PCR analysis (Figure 5).
We observed that all novel target genes are expressed at this
stage and that inhibition of the Nodal pathway in the embryos (SB
treatment) results in significant downregulation of 19 genes
including Nodal. The remaining genes were weakly- or un-affected
by the inhibition of the pathway in embryos. This may be due to
the sensitivity of the RT-PCR or the presence of other factors that
maintain the expression of these genes in the embryo via a Nodal
independent mechanism. Another possibility is that very low levels
of signalling might be still active in SB-treated embryos, sufficient
to maintain the expression of these specific genes. Interestingly, the
majority of these genes contain FoxH1/Smad2 binding sites
(indicated by an asterisk in Figure 5) adding supporting evidence
that they are direct Nodal targets. Collectively, the above data
show that the ES cell system resembles the transcriptional status of
early embryonic development and suggests that the novel target
genes identified here are regulated by Nodal signalling in the
embryo.
The TAG1 database can be used to investigate additional
expression patterns downstream Smad2/3 activation
Recent genome-wide screens in vertebrates and tissues culture
assays have increased the list of genes regulated by Nodal-related
ligands during embryogenesis and other cellular contexts [47,7–
9,6]. However, it is not known whether these genes respond
directly to Nodal signalling over time. We took advantage of our
TAG1 databases to examine the expression profile of at least 150
genes that have been previously identified to be downstream of
Nodal. We initially examined the expression profile of these genes
in the CHX database, which contains genes that are activated by
Smad2/3 in the absence of protein synthesis. We released the p-
value constrain from all time points and selected the genes that
show greater than 1.2 fold ($1.2) upregulation in the first 2 hours,
and that maintain or increase further their expression levels in
4 hours under activation of Smad2/3 in the presence of CHX. For
the genes that are represented by more than one probe on the
microarray chip, we selected those that have at least one probe
following the above criteria. We found that 32 out 150 genes
fulfilled the above criteria (Figure 6A and 6B; Table S5). We then
examined the expression profile of these 32 genes in the presence
of protein synthesis in the two Dox/SB experiments. We selected
genes with upregulation $1.2 fold in the first time point, 6 hours
Figure 4. Expression profile of target-genes downstream a
Smad2/3 activation time-course in the absence of protein
synthesis. Microarray data from TAG1 ES cells under Smad2/3
activation in the absence protein synthesis, as described in Figure 6.
The expression of individual genes was analysed and plotted as trends
over time. Relative level of gene expression is represented as the log
values of fold change (the y-axis) against time (x-axis). All samples were
normalised to the time point 0. Genes are classified in 3 groups
according to the level of response at time point 4 hours compared to 0.
(A) High responding genes, showing $10.0-fold increase. (B) Medium
responding genes, showing $2.5- to ,10.0-fold increase. (C) Last
group comprising the low responding genes ($1.2 to .2.5- fold
increase). For all values see Table 3.
doi:10.1371/journal.pone.0004268.g004
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to be upregulated in 6 hours in the Dox/SB15 experiment and 17
in the Dox/SB12 experiment (Table S6). Only 7 genes (Bambi,
Dkk1, Gadd45g, Omd, Sox17, Syt7 and Zfand5) were in common
between these databases. Notably, Bambi, a BMP/Activin
membrane bound receptor inhibitor [48], and Syt7 (synaptotag-
min VII), a calcium sensor protein that regulates exocytosis [49],
follow faithfully the activation pattern of Smad2/3 in all time
points in both Dox/SB experiments (Figure 6C and Table S6) and
under CHX (Figure 6A and 6B) suggesting that they are direct
targets.
The rest of the 32 known Nodal regulated genes, include factors
with roles during gastrulation such as Chrd, Dkk1, Foxa2, Gata5,
Gata6, Hex, Id3, Lhx1, Otx1, Snail1, Sox17 etc [27,50,51]. These
do not follow the pattern of Smad2/3 activation in ES cells beyond
the first 6 hours, in the presence of protein synthesis. However,
they all respond to Smad2/3 activation in the absence of protein
synthesis (Figure 6A, 6B and Table S5). These genes are normally
activated and expressed at later stages in development and not in
naı ¨ve pluripotent cell environment. Therefore, their expression
may require co-factors not present in ES cells. Alternatively, in the
presence of protein synthesis, repressors that are activated
downstream of Smad2/3 in ES cells could be responsible for
suppressing the premature activation of gastrulation specific genes.
In this study we used criteria to identify genes that follow
faithfully the activation of Smad2/3 over time, and showed that
our database can be used with other criteria to identify target
genes that respond differently. For example the TAG1 database
includes target genes that are downregulated by Alk4*-Smad2/3
activation in the presence or absence of protein synthesis, etc. (not
shown). The above analysis is a proof of principal that our
database is a useful resource to screen for gene regulation
downstream Nodal signalling in ES cells.
Discussion
The transcription effectors Smad2/3 regulate several hundreds
of genes downstream of TGFb ligands, including morphogens
such as Nodal and Activin with essential roles in vertebrate
embryonic development. The concentration of morphogen and
Figure 5. The identified direct target genes are expressed in the mouse embryo under Nodal/Smad2 signalling activation. RT-PCR on
identified direct target genes from E5 embryos cultured with inhibitor (SB) or without (Untr) for 18 hours. All the tested genes are expressed in
uninhibited embryos (Untr). Like Nodal (positive control) the majority of identified target genes are downregulated under SB treatment. No effect on
GAPDH (negative control) expression shows that SB does not generally inhibit gene transcription in cultured embryos. Genes marked with (*) contain
predicted Foxh1 binding elements (ASE).
doi:10.1371/journal.pone.0004268.g005
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PLoS ONE | www.plosone.org 12 January 2009 | Volume 4 | Issue 1 | e4268Figure 6. Expression profile of known Nodal-regulated genes in the TAG1 Smad2/3 time-course databases. Gene expression patterns
of known Nodal-regulated genes were analysed and plotted as trends to show the changes in the expression during the modulation of Smad2/3 in
the absence (A and B) or presence (C) of protein synthesis. Relative level of gene expression is represented as fold-change (y-axis) in log scale
against time (x-axis). All samples were normalised to the 0 time point. Genes with at least one set of probes upregulated ($2-fold) 2 hours after
Smad2/3 activation are shown in (A and B) and genes with one set of probes upregulated ($1.2-fold) 6 hours after Smad2/3 activation in the Dox/
SB15 experiment are shown in (C). The values of fold-change for the genes in these graphs are shown in Tables S5 and S6.
doi:10.1371/journal.pone.0004268.g006
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parameters for specifying cell fate [52,53]. How the cells convert
the concentration of ligand to specific transcriptional responses is
unclear. It is believed that the TGFb morphogen levels are
reflected within a cell by the concentration of activated Smad2/3
effectors, which are then responsible for the downstream
transcriptional responses. However, feedback regulatory mecha-
nisms (positive and negative) are activated directly by P-Smads
over time and alter not only the levels of P-Smads, but also their
transcriptional activity. Correlation of effector levels with expres-
sion patterns of target genes over time had not been addressed in
developmental context.
To obtain insights into this question we generated an inducible
system in ES cells to manipulate the levels of Smad2/3 activation
intracellularly, bypassing all extracellular feedback. We examined
the transcriptional responses at a genome-wide scale at different
time points over the course of 30 hours during which activation of
Smad2/3 is followed by repression of signalling. The experiment
was repeated twice, and only consistent patterns of expression
were studied further. Additionally, to address the response of
direct target genes in the absence of protein-based feedback
mechanism, we performed the activation of Smad2/3 in the
absence of protein synthesis and analysed the transcription
patterns at different time points.
The most important observations of this analysis (summarized
in Table 4) include: (1) the identification of a group of novel target
genes with patterns of expression that follow faithfully and
reproducibly the activation/repression profile of Smad2/3 in the
presence or absence of protein synthesis in ES cells; (2) the finding
that among these genes the most readily responsive were main
feedback factors; (3) the observation that the majority of target
genes follow Smad2/3 activation with similar degree of sensitivity
in the presence or absence of protein synthesis (see classification in
all three experiments), indicating that intracellular feedback
mechanisms acting at the level of P-Smad2/3 activity are
ineffective in ES cells; (4) that the identified direct target genes
are expressed in the early mouse embryo, under Nodal/Smad2/3
signalling, confirming that the ES cell system is relevant to
development; and (5) that most of the direct target genes contain
conserved FoxH1/Smad2 (ASE) binding elements supporting that
they are direct targets. Furthermore, we were able to examine the
expression patterns of known Nodal regulated genes in the
database of our experimental system and identify the ones that are
upregulated in the absence of protein synthesis. This illustrates
how our database can be used for the study of thousands of gene-
expression patterns downstream Nodal-Smad2/3 activation time
course in ES cells.
Efficient manipulation of Smad2/3 activation in ES cells
Smad2/3 activation in ES cells is controlled by the presence of
autocrine signalling but also by extracellular feedback mechanisms
(i.e. agonists, antagonists, co-receptors etc), which alter the
intracellular level of activated Smad2/3 over time. The inducible
system we developed in this study is based on the tetracycline
inducible Alk4*, which bypasses all extracellular feedback. More
importantly, it allowes us to assess transcriptional responses in the
absence of protein synthesis and presumably in the absence of all
protein based feedback mechanisms. The latter was achieve by
Alk4* (Dox) induction in the presence of SB inhibitor and
subsequent activation of Smad2/3 phosphorylation by removing
SB in the absence of protein synthesis inhibition (CHX). Under
these conditions, transcriptional responses were observed as early
as 2 hours after Alk4*-Smad2/3 derepression (Figure 3A). The
response of the target genes was correlated to different levels of
Smad2/3 without protein translation of putative intermediate
feedback factors. However, as microarrays is a semi-quantitative
method, quantitative PCR is needed to allow accurate correlation
in future experiments. Moreover, evaluation of transcription rate
and mRNA stability should also be studied, as they can also
modulate the sensitivity of the transcriptional responses. Such
studies may reveal mechanisms of differential gene expression
downstream specific concentrations of P-Smad2/3. Finally, as our
ES cell system is relevant to development it could be used to
manipulate signalling at different periods during differentiation in
vitro and lead to the identification of key target genes in different
cellular context.
Identification of novel Smad2/3 primary target genes in
ES cells
It has become apparent that the regulation of genes involves
combination of transcription factors and enhancer elements,
conferring tissue specificity and response to signalling effectors.
This means that the target genes downstream signalling are
expected to be different and specific to a cell type or tissue. It is
therefore important to screen for Nodal/Smad2/3 target genes in
ES cells as these represent a developmental relevant context. Here
we identified 54 novel gene that follow faithfully and reproducibly
the changes of Smad2/3 activation. More than half of these target
genes (33 total, 27 novel) were also significantly upregulated after
only 2 hours of Smad2/3 activation in the absence of protein
synthesis, confirming that they are primary targets and not
secondary (which depend on the activation of intermediate
transcriptional activators and co-factors). In addition, we showed
that these genes are expressed in the mouse embryo at stages
where Nodal signalling is active; and are downregulated when
Nodal signalling is inhibited (with SB treatment of the embryos),
supporting the hypothesis that they are Nodal-Smad2/3 targets
relevant to developmental events. Furthermore, the fact that these
primary target genes contain conserved FoxH1/Smad2 binding
elements (also known as ASE and ARE [32,33]), strengthens the
hypothesis that they are directly regulated by Nodal signalling.
However, as Nodal-Alk4* signalling can phosphorylate additional
effectors other than Smads [40], we cannot exclude that some of
these targets may be Smad independent.
Duration of Nodal-Smad2/3 signalling and its effect on
transcriptional responses
Duration of signalling is an important parameter for the
transcriptional responses downstream of Nodal-Smad2/3, as
primary early target genes include feedback proteins, which affect
the strength of subsequent signalling can reset the pattern of
expression over time. The list of genes that are reproducibly
activated in the two Dox/SB experiments includes Nodal itself and
its co-receptor Cripto [54] as well as Nodal antagonists Lefty1/2 [55]
and Bambi (BMP and Activin membrane-bound inhibitor; ([56]
and reviewed in [57,30]). These genes are part of the extracellular
feedback mechanism of TGFb signalling and their role is to
change the levels of Smad2/3 activation. In our inducible system,
however, extracellular factors are bypassed as activation of
Smad2/3 depends on Alk4* induction by Dox. Western blotting
confirmed that maximal activation occurs 3–6 hours after Dox
treatment (Figure 1C), and is maintained at peak levels over a long
period (24 hours Figure S1).
Early-activated genes in our system also include negative
intracellular regulators of TGFb signalling, such as inhibitory
Smad7 (I-Smad7) and the co-repressors SnoN and Ski. I-Smad7
has been proposed to interfere with Smad-DNA complex
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Gene Dox/SB15 CHX ASE
Expression in
E6 embryo
Expression in
E6 embryo +SB Status
1443256_at M L 1 N/A N/A Novel/Direct
5730419I09Rik L - N/A N/A N/A Novel
Aasdhppt L - N/A N/A N/A Novel
Abcg2 L - N/A N/A N/A Novel
Atrx L - N/A N/A N/A Novel
AW548124 M M 2 ++ +/2 Novel/Direct
B3galt3 L - N/A N/A N/A Novel
Bbc3 L - 0 N/A N/A Novel
BC037674 L - N/A N/A N/A Novel
Bcar3 M L 0 ++ -- Novel/Direct
Bhlhb8 L - N/A N/A N/A Novel
Camk2n1 M M 0 ++ /2 Novel/Direct
Ccnd2 L - N/A N/A N/A Novel
Cd97 M L 2 ++ +/2 Novel/Direct
Cnpy1 M L 1 ++ -- Novel/Direct
Cripto L - N/A N/A N/A K
D030056L22Rik L L 0 ++ + Novel/Direct
D6Wsu176e L - N/A N/A N/A Novel
Dppa2 L - N/A N/A N/A Novel
Dusp9 L - N/A N/A N/A Novel
Duxbl M M No + -- Novel/Direct
Eif3s6ip L - N/A N/A N/A Novel
Epha2 L L 0 ++ + Novel/Direct
Fbxl20 L L 4 ++ +/2 Novel/Direct
Fgf15 H - 1 ++ -- Novel
GalNAcS-6ST H H 0 + -- Novel/Direct
Gpr107 L - N/A N/A N/A Novel
Hrb L - 1 N/A N/A Novel
Khsrp L - N/A N/A N/A Novel
Lefty1 H H 1 ++ -- K
Lefty2 H M 1 N/A N/A K
Lgr4 M - N/A N/A N/A K
Mcl1 L L 1 ++ + Novel/Direct
Moap1 L L 0 ++ -- Novel/Direct
Mrpl15 L - N/A N/A N/A Novel
Nfkbia L L 0 ++ +/2 Novel/Direct
Nodal L L 1 ++ -- K
Notch3 L - N/A N/A N/A Novel
Nphs1 L - 1 N/A N/A Novel
Nxn M L 4 ++ /2 Novel/Direct
Pcdh8 M L 0 N/A N/A Novel//Direct
Pea15 L - N/A N/A N/A Novel
Pitx2 H H/M 3 ++ + K
Plekha2 M L 1 ++ +/2 Novel/Direct
Ppp1r2 L - N/A N/A N/A Novel
Pycr2 M L 0 ++ +/2 Novel/Direct
Rasd2 L L 0 ++ + Novel/Direct
Rhob L M 0 ++ + Novel/Direct
Schip1 L L N/A ++ +/2 Novel/Direct
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activation, while SnoN (Ski-like) interacts directly with Smad2/3
and Smad4 and blocks target gene transcription [62,63]. These
negative regulators act on activated Smad2/3 and therefore are
expected to reduce target gene transcription with duration of high
signaling. However, this was not observed in our system, as the
identified target genes are not repressed at 12 or 15 hours under
induction. Furthermore, in the absence of protein synthesis, where
there are no or little protein dependent feedback mechanisms
target genes responded with the same sensitivity as in the presence
of protein synthesis (Table 1 and Table 3). Longer periods
(.15 hours) of Smad2/3 activation in the presence of protein
synthesis is needed to address when the negative regulators repress
P-Smad transcriptional activity. Notably, in the experiment where
Dox was maintained up to 30 hours in the TAG1 cells, Nodal
expression (downstream Smad2/3 activation) peaked at 12–
20 hours and declined slowly after that (Q-PCR; Figure S1B).
As P-Smad2 levels are maintained high throughout this exper-
iment (Figure S1A) the cause of the downregulation at 30 hours is
most likely caused by intracellular negative feedback mechanisms,
which commence after a 24-hour duration of signalling in ES cells.
The levels of I-Smad7 and co-repressor SnoN are also regulated at
the protein level by ubiquitin ligases such as Arkadia, Smurf2 and
Anaphase PromotingComplex[64–68].Arkadia ispresentin ES cells
[19] and it controls the levels of Ski/SnoN and I-Smad7 and cancels
their negative feedback. We did not find evidence that Arkadia
expression is regulated by Smad2/3 (TAG1 database) and therefore,
we concluded that this mechanism is present in ES cells and
independently of Alk4*-Smad2/3 signalling. Interestingly, we do not
find positive regulators, such as partner transcriptional factors FoxH1
and Mixl1, to be activated downstream of Smad2/3 in ES cells.
Nevertheless, FoxH1 is already present in ES cells [19] and the
majority of the genes on our list contain FoxH1 binding sites. As
partner factorsdetermine target gene specificity and are not subject to
Smad2/3 regulation, they represent important components of target
gene selection in a specific cell context. Therefore, ES cells show bias
towards FoxH1 target gene activation and corresponding cell fate [9]
suggesting that ES cells are pluripotent but not naı ¨ve.
Collectively our analysis suggests that in ES cells and most likely
during development, graded levels of activated Smad2/3 effectors
are converted proportionately into several target gene expression
and that these responses remain sensitive and reversible over a
24 hour period. However, maintenance of signalling over long
time leads to the activation of secondary and tertiary transcription
factors. These can cause cross-repression or cross-enhancement of
primary genes or activate new genes further downstream. Notably,
Pitx2, an immediate early transcription factor target whose
expression is solely dependent on Smad2/3 activation in ES cells,
is expected to be involved in major downstream transcriptional
effects. Further long-term experiments are required to address
when and how the Smad2/3 transcriptional responses become
desensitised and fixed leading to a particular cell fate. However,
our study is in a population of cells, and the culturing conditions
most likely favour maintenance of the ES cells undifferentiated
character (self-renewal and proliferation). Single cell analysis and
culturing under differentiation condition of the TAG1 induced
cells should be more informative on lineage commitment
mechanisms downstream Smad2/3 signalling.
Our system can be used in the future for studies of different
expression patterns downstream Nodal-Smad2/3 activation (i.e.
downregulated genes) and also for studies under different culturing
conditions i.e. long exposure to low versus high levels of Smad2/3
activation; or in combination with a different signalling pathway
stimulation; etc. Such studies will shed light on the understanding
of how time and level of the Nodal/TGFb effectors select target
genes. As Smad2/3 signalling is involved in several functions, from
ES cell pluripotency to differentiation towards lineages including
endoderm, and in diseases like cancer, our system and results will
be useful to a range of scientists addressing diverse subjects.
Materials and Methods
All experiments done on animals were performed under a UK
Home Office Animal licence and approved by the Imperial
College ethical review committee.
Cell culture/Derivation of TAG1 cell lines
TAG1 ES cells were generated by co-electroporation of two
constructs into feeder free doxycycline inducible J1 ES cells (gift of
Anton Wutz, Austria). The constructs were: the pSLTT-AIG
Gene Dox/SB15 CHX ASE
Expression in
E6 embryo
Expression in
E6 embryo +SB Status
Ski L - 0 N/A N/A K
Slc7a7 M L N/A ++ + Novel/Direct
Smad7 M M N/A ++ /2 K
SnoN L L N/A ++ -- K
Sntb2 L - N/A N/A N/A Novel
Tmem63a M M 0 + -- Novel/Direct
Tmepai L/M M 0 ++ + Novel/Direct
Ttc13 L - N/A N/A N/A Novel
Novelbr7 L L 1 ++ +/2 Novel/Direct
Zcchc11 L L 3 ++ /2 Novel/Direct
Zfp423 L L 5 ++ +/2 Novel/Direct
The genes are listed in alphabetical order. The classification high (H), medium, (M) low (L), corresponds to the sensitivity of their response to Alk4
*-Smad2/3 activation
during the time course experiment in the presence (Dox/SB15) or absence (+CHX) of protein synthesis. The presence and number of FoxH1 (ASE) binding sites is
indicated. The expression in the embryos with or without SB inhibitor is listed and scored (+, 2). N/A, not analysed; Novel, identified target; K, previously known target;
doi:10.1371/journal.pone.0004268.t004
Table 4. cont.
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(Novagen, UK) linearised at the MluI site and were represented
10:1 ratio in the total 25 mg of DNA electroporated. The
electroporation was performed with 20610
6 cells at 0.2kV and
960 mF on the Gene Pulser System (Bio-rad, UK). The J1 cells
were selected in ES cell medium: 15% FCS in DMEM (Invitrogen,
UK) supplemented with LIF (homemade) (ES cell medium) and
selected wtih 110 mg/ml hygromycin (Invitrogen) 48 hours after
electroporation. ES cell colonies were picked and screened for
inducibility by ES cell medium containing 1 mg/ml of doxycycline
for 18 hours. Colonies were detection for GFP fluorescence under
UV on a Leitz DMIRB microscope (Leica Microsystems, UK).
Clones were picked and expanded. The TAG1 ES cell line was
maintained feeder-free in 20% FCS in DMEM supplemented with
LIF.
Manipulations of Smad2/3 signalling/activation in TAG1 ES
cells were performed under chemically defined conditions using
DMEM supplemented with 20% KSR (KSR media). Induction of
the TAG1 ES cells was performed using KSR medium supple-
mented with 1 mg/ml doxycycline (Clontech, UK). Inhibition of the
TAG1 ES cells was performed using KSR medium containing
10 mM SB-431542 (Sigma, UK and gift from GSK, UK). As
DMSO was used to dissolve doxycycline, the control ES cells were
treated with 0.1% DMSO (Sigma, UK). For the identification of
direct transcriptional targets, the TAG1 ES cells were cultured in
KSR media containing 10 mM SB-431542 and 1.5 mg/ml
doxycycline for 6 hours to accumulate Alk4* receptors while
inhibiting their activity. This medium was then replaced with fresh
containing only 100 mg/ml cycloheximide (Calbiochem, UK). In
the uninduced control experiment, the TAG1 ES cells were treated
with 100 mg/ml cycloheximide and 10 mM SB-431542.
Western Blotting
Immunochemistry was carried as described before [19].
Primary antibodies used were: rabbit anti-P-Smad2 (1:2000)
(Calbiochem, UK), rabbit anti-Smad2 (1:2000) (Zymed Labora-
tories, USA), rabbit anti-P-Smad3 (1:1000) (Cell Signaling
Technology, USA) or mouse anti-PCNA (1:5000) (Santa Cruz
Biotechnology, USA). Secondary antibodies were: HRP conjugat-
ed anti-rabbit (1:2000) (GE Healthcare, UK) or anti-mouse
antibody (1:5000; Santa Cruz Biotechnology, USA) Quantitation
of protein bands were performed on scans of the films and
measurements of pixel intensity for each band on Photoshop 7.0
(Adobe Systems Inc., USA).
FACS sorting
ES cells were harvested using trypsin (Invitrogen), gently
dissociated into a single-cell suspension, and resuspended in ice
cold PBS at a density of 1610
5 cells/ml. FACS analysis was
carried out on the FACScan Flow Cytometry System (Becton,
Dickinson and Company, USA) using the CellQuest analyser
program.
Microarray analysis
Total RNA was extracted from cells using the RNeasy Mini Kit.
Concentration and quality of the RNA was checked on the
NanoDropH ND-1000 Spectrophotometer (NanoDrop Technolo-
gies, USA) and the RNA 6000 Nano LabChipH Kit (Agilent
Technologies, UK) on the 2100 Bioanalyzer (Agilent Technolo-
gies). 10 mg of total RNA for each sample was reverse transcribed
using SuperScript
TM II Reverse Transcriptase (Invitrogen) follow-
ing the manufacturer’s protocol. The first cDNA strand reaction
was used for second cDNA strand synthesis with DNA Ligase,
DNA Pol I, dNTPs and RNase H (Invitrogen). The double
stranded cDNA was further purified using the GeneChip Sample
Cleanup Module (Affymetrix, UK). The double stranded cDNA
was then transcribed into biotin labelled cRNA using the Bioarray
High Yield RNA Transcript Labelling Kit (Enzo Diagnostics,
USA) according to the manufacturer’s protocol. The cRNA was
cleaned-up again using the GeneChip Sample Cleanup Module.
Concentration and absorbance ratios of the cRNA was checked on
the NanoDropH ND-1000 Spectrophotometer and the quality
evaluated on the 2100 Bioanalyzer for a smear of products ranging
from 500–3000bps.
Labelled cRNA was fragmented by the MRC CSC Microarray
Centre and each sample was hybridised to a GeneChipH Mouse
Genome 430 2.0 Array (Affymetrix, USA) as specified by the
manufacturer. Further details on the microarray hybridisation are
available at the MRC/CSC/Imperial College Microarray Centre
website (http://microarray.csc.mrc.ac.uk). Microarray data were
analysed on the Rosetta ResolverH Gene Expression Analysis
System (Rosetta Biosoftware, USA). Hybridisations or profiles for
each sample in the TAG1 time course were grouped in an
experimental definition and subjected to interchip normalization
and nonlinear error correction to create ratio experiments. Log10
ratios between each sample in a time course were computed
generating all possible pairwise comparisons of the time points. An
error weighted average of the expression signal ratio and P value
was calculated for each gene in each pairwise comparison.
Changes in gene expression were considered as statistically
significant if the calculated P value was equal to or below a
threshold of 0.01.
The annotated information for each target genes is shown in
Table S7. The information was compiled from the Mouse
Genome Database http://www.informatics.jax.org/[69], Entrez
Gene http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene [70]
and Gene Ontology http://www.geneontology.org/[71]. Gene
expression in the different tissues and at different stages was
curated from cDNA source data provided in the Mouse Genome
Database.
Embryo culture
For inhibition of Nodal/Smad2/3 signalling, embryos from
CD1 inter-cross litters were dissected in ice cold PBS supplement-
ed with 1% FCS on E5 or seventh E6 and cultured for 18 hours in
1:1 DMEM: rat serum containing 20 mM of SB-431542 (Sigma) or
0.2% DMSO alone as a control in a 37uC, 5% CO2 incubator.
Total RNA was extracted using TrizolH Reagent according to the
manufacturer’s protocol.
Luciferase assays: as described before [19]
RT-PCR and Real-time qRT-PCR: as described before [19]
Primer Sequences for housekeeping genes were described in [72].
Gene-specific primer sequences were obtained from PrimerBank
(http://pga.mgh.harvard.edu/primerbank/index.html)
Identification of ASE elements, CAGA boxes and
multispecies sequence conservation
The sequences of interest were retrieved from NCBI or
Ensembl. These included 10 kb upstream and downstream of
the first and last exon. Potential ASE binding sites and CAGA
boxes were identified using Fuzznuc, a program of the EMBOSS-
MS software, which allows fuzzy searching of nucleic acid patterns
using IUPAC codes and variable spacing between binding sites.
Potential ASE binding sites were identified using the rule that two
AATMMACA consensus sequences are separated by 30–200
bases, where M is C or A. In order to cover all possible patterns
that correspond to an ASE element, the following rules were also
tested: 1) TGTKKATT, 30–200 bp space followed by
Smad2/3 Target Gene Profiling
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bp space followed by TGTKKATT or 3) TGTKKATT, 30–200
bp space followed by AATMMACA. Potential CAGA boxes were
identified using the consensus AGMCAGACA or its reverse
complement sequence TGTCTGKCT.
Multiple alignments of the genic sequences including 10 kb
upstream of the first exon and 10 kb downstream of the last exon
of genes that were predicted to contain ASE elements were
generated and visualized using MULTIPIPMAKER (http://
pipmaker.bx.psu.edu/pipmaker). In MULTIPIPMAKER, the
reference mouse sequences were compared with the corresponding
human, chimp, rat and dog genomic sequences in order to identify
regions of high conservation across species. These regions were
then manually inspected for the conservation of the predicted ASE
elements.
Supporting Information
Figure S1 Alk4* induction phosphorylates efficiently Smad2 and
activates endogenous Nodal expression in TAG1 cells (A) Western
blot analysis of total Smad2, P-Smad2, and PCNA (loading
control) in TAG1 ES cells treated with: DMSO control medium,
SB inhibitor (dissolved in DMSO), or Dox (dissolved in DMSO)
for the time period indicated in hours. Bar chart represents
densitometry analysis of the bands on the western bolt. P-Smad2
levels were normalised against total Smad2. All values are
expressed relative to the DMSO control, which is represented as
100% on the chart. (B) Quantitative Real-Time PCR of Nodal
transcripts in TAG1 cells at different time points (indicated in
hours) are shown with blue line for DMSO treated cells, with red
for SB, and with green for Dox. Relative transcript abundance is
shown on the y-axis and time points on the x-axis, as indicated. All
cells were pre-treated with SB for 6 hours (26 +SB). Relative
Nodal transcript abundance is expressed as the average of four
PCR reactions (n=4) normalised to the expression of the
housekeeping genes: Gapdh, Ube, Ywhaz and B2m, with standard
error the mean of the PCR reactions.
Found at: doi:10.1371/journal.pone.0004268.s001 (3.74 MB TIF)
Figure S2 Validation of gene expression downstream Smad2/3
activation and inhibition in TAG1 ES cells. Semi-quantitative (A)
and quantitative (B and C) RT-PCR for selected genes at different
time points after Smad2/3 activation (+Dox) and inhibition (+SB),
as indicated in hours. In (A) PCNA housekeeping gene expression
was used as control gene; +, with reverse transcriptase; 2, without.
In (B) and (C) the relative transcript abundance was normalised to
that of the housekeeping genes Gapdh, Ube, Ywhaz and B2m (y-
axis) and shown at different time points (x-axis) during activation
as indicated. The experiments were repeated three times with
similar results (not shown).
Found at: doi:10.1371/journal.pone.0004268.s002 (6.20 MB TIF)
Figure S3 Pipplots of the genomic sequence comparisons
between mouse, human, chimp, rat and dog. For each gene, the
reference sequence on top is the mouse sequence and the boxes
underneath represent the corresponding sequences in the other
species. Short black lines in the rectangles represent sequence
similarities greater than 50% between the reference and the other
species. The presence and position of the ASE elements in the
sequence comparisons is illustrated by the red rectangles.
Found at: doi:10.1371/journal.pone.0004268.s003 (3.43 MB TIF)
Figure S4 Sequence conservation of the ASE enhancer elements
in known and novel Smad2/3 target genes. A black dot indicates
conservation of a base between the reference (mouse) and the
other species, while an alternative base indicates the difference.
The ASE elements are enclosed in red rectangles. In (A), the
predicted ASE element in the genic sequence of Nodal, a known
Smad2/3 target, is conserved in all species tested; the ASE element
in Ubr7 gene shows medium conservation only in rodents; for the
CD97 gene, one ASE is not conserved and the other conserved
only in rodents. The predicted ASE elements in the genic sequence
of the known Smad2/3 target genes Pitx2, Lefty1 and Lefty2 is
conserved in all species tested (B). The first predicted ASE
elements in the genic sequence of Zfp423 gene is conserved in all
species tested, while the remaining ASE elements have been
modified by insertions (second ASE), point mutations of important
nucleotides (third and fourth ASE) or deletions (fifth ASE) in the
human and chimp (C).
Found at: doi:10.1371/journal.pone.0004268.s004 (10.16 MB
EPS)
Table S1 Behaviour and classification of gene expression in the
Dox/SB15 experiment.
Found at: doi:10.1371/journal.pone.0004268.s005 (0.09 MB
PDF)
Table S2 Behaviour and classification of gene expression in the
Dox/SB12 experiment
Found at: doi:10.1371/journal.pone.0004268.s006 (0.07 MB
PDF)
Table S3 Upregulated genes downstream Smad2/3 activation
in the absence of protein synthesis
Found at: doi:10.1371/journal.pone.0004268.s007 (0.06 MB
PDF)
Table S4 Analysis by Fuzznuc for the existence of ASE elements
and CAGA boxes Summary of the genomic coordinates, exact
binding site and position of ASE elements with regard to the gene
start. Genes that did not show significant fold-change in the
absence of protein synthesis (1) and are used as controls. bp (base
pairs); Ch (chromosome)
Found at: doi:10.1371/journal.pone.0004268.s008 (0.02 MB
XLS)
Table S5 Behaviour of selected known Nodal-regulated genes in
TAG1 ES cells during Smad2/3 activation in the absence of
protein synthesis
Found at: doi:10.1371/journal.pone.0004268.s009 (0.06 MB
PDF)
Table S6 Behaviour of selected known Nodal-regulated genes in
TAG1 ES cells during Smad2/3 activation and repression in the
presence of protein synthesis
Found at: doi:10.1371/journal.pone.0004268.s010 (0.07 MB
PDF)
Table S7 Functional annotation of Smad2/3 target genes
Found at: doi:10.1371/journal.pone.0004268.s011 (0.11 MB
PDF)
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